Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
Can biology move at "internet speed"? Is there a Moore's Law for cells? What about the problems that cannot be solved by information technology alone? IndieBio is proposing to answer these questions and more. 
No comment yet.
Sign up to comment
Scoop.it!
The drug company GlaxoSmithKline hopes that making its research available to scientists will lead to safer, more effective drugs. Whether more disclosure might lead to safer, more effective drugs remains to be seen. GlaxoSmithKline, a British drug concern, will open its clinical trial data to other researchers once a drug has completed the approval process or been abandoned. Glaxo is taking the step after experimenting with disclosure for treatments for tropical diseases like malaria and finding those efforts successful, according to company officials. In addition, the company plans to release information about 200 of its experimental drug compounds that have shown signs of fighting tuberculosis. Learn more by clicking on the image or the title.
|
Scoop.it!
PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world.
Phillip Trotter's insight:
The oceans role as a viral and microbiological ecosystem is not well understood these findings are an important step in beginning to address that. Interesting paper. Click on image or title to learn more.
Scoop.it!
Good Article on Craig Venter By Thomas Goetz. in 1992 Venter left the National Institutes of Health (NIH) to head the nonprofit Institute for Genomic Research. Six years later he founded Celera Genomics, a rival to the NIH project that aimed to sequence the full code of the human genome. In 2001 Celera officially “tied” the NIH to the genome finish line, though the company’s sequence was more than a bit further along. In 2004 he sailed around the world, discovering thousands of new species and sequencing millions of new genes. In 2007 he unveiled his own genome and in 2010 he announced the first successful synthesis of life—a unique critter borne from two distinct organisms, thus proving for the first time that it is indeed possible to create new organisms for specific purposes and functions. More at http://bit.ly/JEbBxS Via Gerd Moe-Behrens
Scoop.it!
BioPortfolio.com - the life science and healthcare portal BioPortfolio brings our visitors continuously updated biotechnology, pharmaceutical and healthcare n...
|
IndieBio will likely be a bell weather fro how life sciences are adapting to accelerated rates of innovation and discovery - as well as a center point for policy, public perception and discourse. Good article - worth reading for insight into life sciences and biotech incubation as of 2015.